Keep up with the latest news, events, and stories about Ofmom
COREE Company has signed a strategic partnership agreement with Infini Fluidic of the U.S. to develop a new method in the microfluidic process producing mRNA vaccine lipid nanoparticle structures.
A joint marketing campaign has been launched for SynterAct, a probiotic supplement consisting of 3P biotics developed for different age groups from babies to seniors, and DeRAMA.
COREE Group will push its own platform, "life intervention", into the US market with the ability to improve living habits and predict diseases. Its goal is to obtain a license for the medical software (SaMD•Software as Medical Device) from the Food and Drug Administration (FDA).
Representatives and experts from Peking Union Medical College Hospital, Beijing Children’s Hospital, PKU China Center for Health Development Studies, Embassy of the Republic of Korea, Coree-Ofmom (HK) came together at Centre Ofmom in Beijing to formalize an international research project on women’s welfare and children’s healthcare on 3 December, 2017.
The market size of the current global milk powder is about 292.7 billion yuan. Taking into account the annual growth rate of about 6%, it is expected to reach 310.2 billion yuan in 2017. In terms of sales, China’s milk powder market in the year 2015 reached 122.1 billion yuan, it is expected to reach 204.1 billion yuan in 2018. For this huge milk market, Ofmom Company reveals the grand blueprint and launches a challenge.